Bayer Satisfies DoJ ‘Need To Know’ About Probiotic Claim Studies
This article was originally published in The Tan Sheet
Executive Summary
A judge also grants Bayer’s request to depose an FTC attorney about the agency’s investigation that led to a contempt charge linked to allegedly violating a 2007 consent decree by making a drug claim for the Phillips’ Colon Health three-bacteria-strain formula.